Electroducer Sleeve

The Electroducer Sleeve is a medical device used during percutaneous cardiovascular interventions (PCI* AND TAVR).

*PCI is only claimed for the European market

Integrating at best the Direct Wire Pacing (DWP®) technique,
the Electroducer Sleeve aims to improve, secure and standardize it.

Electroducer device

The Electroducer Sleeve is an electro-conductive device made of highly innovative material which is intended to transmit, in a safe way for the patient, the electrical signal from an external pacemaker to the heart through the guidewire.

Thanks to multi-patented technologies, Electroducer Sleeve integrates the Direct Wire pacing technique at the best, increasing the technique reproducibility with a good assessment of the pain by the patients and acceptable thresholds.

*Electroducer First In Man Pilot study- EuroPCR 2021
*PCI: Percutaneous Cardiovascular Interventions
*TAVR: Transcatheter Aortic Valve Replacement
*The Electroducer® Sleeve is under development. Its properties, performance and safety are still under evaluation. It is not available yet for use. As a medical device, it does not yet comply with Regulation (EU) 2017/745. Electroducer® Sleeve is not CE marked.

The Electroducer Sleeve interfaces with the conventional percutaneous cardiac procedure equipment:
it does not change physicians’ habits, thus allowing a better adoption of the technique.

Users’ feedbacks

“I’m convinced that within a few years, this device will replace temporary pacing lead for interventional procedures.”

Dr Thierry Lefevre, co-Principal Investigator of Jacques Cartier Hospital in Massy, Electroducer First In Man Pilot study.

“A major step towards simplification of interventionnal procedures requiring temporary cardiac pacing.”

Dr Nicolas Dumonteil, co-Principal Investigator of Clinique Pasteur in Toulouse, Electroducer First In Man Pilot study.

“The more you use it, the more you like it!”

Dr Mohamed Abdellaoui, co-Principal Investigator of Groupe Hospitalier Mutualiste in Grenoble, Electroducer First In Man Pilot study.

“A safe and efficient device for transcatheter heart valve and complex PCI procedures requiring temporary pacing.”

Pr Jérôme Wintzer, interventinal cardiologist at Cardiovascular Institute at Groupe Hospitalier Mutualiste de Grenoble.

“A disruptive and simple device allowing to simplify coronary and structural procedures.”

Pr Jacques Monségu, interventional cardiologist and head of the Cardiovascular Institute at Groupe Hospitalier Mutualiste de Grenoble.